Volumetric neuroimaging and low-dose early-life exposures: loose coupling of pathogenesis-brain-behavior links.
The interface of developmental neuroimaging with developmental neurotoxicology can, broadly speaking, address two complementary concerns. The first is to study the impact of specific exposures on brain development. The second is to study known neurobehavioral disorders with an eye to discerning toxicological contributions to pathogenesis. Pathogenesis targets brain based upon physical properties (receptors, growth factors, etc.) while behavior is modulated by regional and neural systems alterations. The distribution of pathogenesis-brain relationships overlaps only partially with that of brain-behavior relationships. The goal of this paper is to highlight methodological issues involved in designing and interpreting volumetric neuroimaging studies in the light of this loose coupling.
Herbert
Martha R
MR
Pediatric Neurology, Center for Morphometric Analysis, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Room 6012, Charlestown, MA 02129, USA. mherbert1@partners.org
Ziegler
David A
DA
D001519:Behavior / Q000187:drug effects*; D001921:Brain / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D002658:Developmental Disabilities / Q000139:chemically induced / Q000473:pathology / Q000523:psychology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007806:Language Disorders / Q000139:chemically induced / Q000473:pathology / Q000523:psychology; D020258:Neurotoxicity Syndromes / Q000473:pathology / Q000523:psychology*